The global tissue imaging market is projected to be worth USD 27.32 Billion by 2027, according to a current analysis by Emergen Research. The tissue imaging market is observing high demand attributed to growing incidence of chronic diseases. The swiftly growing burden of chronic diseases across the globe are fueling the market growth. According to the statics released by WHO (World Health Organization), the burden of chronic diseases is projected to grow by 57.0% by the year 2020 from 2001. Developing nations are expected to be highly impacted, contributing to 60.0% of the global burden of chronic diseases.
An increase in healthcare expenditure and increased funding for healthcare R&D are significantly driving the tissue imaging market growth. The healthcare expenditure in the US reached USD 3.60 trillion in 2018, an increase of 4.6% from the previous years. This rise in spending is, to some extent, faster as compared to the increase in 2017 from 2016.
The research takes a closer look at prominent factors driving the growth rate of the prominent product categories across major geography. Furthermore, the study covers a lot of the sales, gross margin, consumption capacity, spending power and customer preference across various countries. The report offers clear indications how the tissue imaging market is expected to witness numerous exciting opportunities in the years to come. Critical aspects including the growing requirement, demand and supply status, customer preference, distribution channels and others are presented through resources such as charts, tables, and infographics.
Read more@ https://www.emergenresearch.com/industry-report/tissue-imaging-market
Key Highlights From The Report
In March 2019, Abcam PLC signed a collaborative agreement with Visikol, a CRO emphasized on drug discovery advancement, for the development of new kits and reagents for enhanced tissue 3D imaging and clearing.
In situ hybridization provides several benefits encompassing imaging and diagnosis of frozen tissues, along with its application in combination with immunohistochemistry for research and analysis of protein and mRNA.
According the statistics published by the American Cancer Society, male population in the age group of 65 years or above are 66.0% more likely to suffering from prostate cancer. Further, prostate cancer is the second leading cancer accountable for American men mortality.
Pharmaceutical Companies held a significant share of tissue imaging market in 2019 due to wide spread of tissue imaging in the drug development process and other analytical processes.
The rapid rise of the tissue imaging market demand in the Asia Pacific region is due to the rising incidence of chronic and infectious conditions, flourishing pharmaceutical and biotechnology industry, and a rise in research and development activities associated with imaging procedures in the region.
Key participants include Abcam PLC, Bio-Rad Laboratories, Becton, Dickinson, and Company, Fluidigm Corporation, Abbott Laboratories, Agilent Technologies, Biocare Medical, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Nikon Corporation, among others.
Request For Free Sample@ https://www.emergenresearch.com/request-sample/362
Technology Outlook (Revenue, USD Billion; 2017-2027)
Mass Spectroscopy
Immunohistochemistry
Flow Cytometry
Digital Pathology
In Situ Hybridization
Immunofluorescence
Others
Products Outlook (Revenue, USD Billion; 2017-2027)
Platforms
Microscopes
Consumables
Software
Accessories
Application Outlook (Revenue, USD Billion; 2017-2027)
Disease Research
Oncology Research
Infectious Diseases Research
Neurological Disease Research
Cardiovascular Disease Research
Immunological Disease Research
Others
Diagnostics
Oncology Diagnostics
Infectious Diseases Diagnostics
Neurological Disease Diagnostics
Cardiovascular Disease Diagnostics
Immunological Disease Diagnostics
Others
End-Users Outlook (Revenue, USD Billion; 2017-2027)
Hospitals & Clinics
Pharmaceutical Companies
Research Institutes
Others
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA
Table of Content
Chapter 1. Methodology & Sources
1.1. Tissue Imaging Market Definition
1.2. Tissue Imaging Market Research Scope
1.3. Tissue Imaging Market Methodology
1.4. Tissue Imaging Market Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Tissue Imaging Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Tissue Imaging Market Segmentation & Impact Analysis
Continued
